1 / 17

Background (1)

Innovative peer-to-peer educational intervention to reduce HIV and other blood-borne infection risks in difficult–to-reach people who inject drugs: results from the ANRS AERLI study.

carlow
Download Presentation

Background (1)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Innovative peer-to-peer educational intervention to reduce HIV and other blood-borne infection risks in difficult–to-reach people who inject drugs: results from the ANRS AERLI study Patrizia Carrieri, Jean-Marie Le Gall, Marie Debrus, Baptiste Demoulin, Caroline Lions, Aurélie Haas, Marion Mora, Perrine Roux, Marie Suzan-Monti, Bruno Spire

  2. Background (1) • French harm reduction policies havecontributed to vastly reduceHIV incidence among people who inject drugs (PWID) • ~1% of new HIV diagnoses in 2012 • However, complications related to injecting practices remain • High prevalence of Hepatitis C Virus (HepC) infections • Needle/syringe and paraphernalia sharing • Other intravenous drug use related complications • Local lesions : venous damage, abscesses, cellulitis, other skin infections • Cardiovascular and pulmonary complications

  3. Background (2) • Existence of persisting at-risk behaviors suggests that current Harm Reduction Programs are insufficientfor PWID • Opiate substitution treatments • Needle/syringe programs • Support services • Need to experiment with, evaluate and implement alternative and innovative strategies that effectively improve the health of this population

  4. Objective • The objective was to assess the effectiveness and feasibility of a community-based training and education intervention on reducing injection-associated risks • Viral infections (HIV, HepC) • Other injection-related damages • AIDES and Médecins du Monde staff members or volunteers were involved in study design, training of peers, performing the intervention, collecting and analyzing the data

  5. Study design (1) • National multi-site community-based study comparing the evolution of injection- related risks over one year in low-threshold services, hold by AIDES and MDM, between: • An intervention group, comprising people benefitting from educational sessions in 8 participating services • A control group, comprising people recruited in 9 services, working in accordance with current guidelines

  6. Study design (2) Educational sessions (ES) with PWID = educational tailored intervention by NGO staff member/volunteer after observation of participants’ self-injection practices Phone interviews with an independent trained interviewer not involved in the ES At least1 ES over 5 months Intervention group Control group Inclusion M6 M12

  7. Methods (1) • Eligibility criteria • ≥18 years old; injecteddrug at least once during the previous week; willing to be contacted for a phone interview; able to provide written informed consent • Data collection • Phone interviews at M0, M6 and M12 collecting : • socio-demographic characteristics • behaviors related to HepC transmission risk (BBV-TRAQ) • experience with drug use; history of incarceration • access to care; HIV, Hep C and B testing and diagnosis • motivational factors for willing to participate in the intervention • Data from the intervention sessions were collected by community-based association members

  8. Methods (2) • Analyses • Outcomes • Having at least one at-risk practice for HepC transmission in the previous month • Having at least one local complication at the injection site • 2-step Heckman model to avoid possible selection bias arising from the clustering of intervention (n=113) and control groups (n=127) • 1st step: probit model to identify baseline factors associated with exposure to the ES to compute the inverse Mills ratio (IMR) • 2nd step: probit mixed model to identify factors associated with each outcome after introducing the IMR to control for the clustering bias

  9. Study sample diagram Control sites n=9 Intervention sites n=8 Participants who did not receive ES N=31 288 ES

  10. Results (1) – Participants’ characteristics Baseline characteristics (n (%) ormedian [IQR]), ANRS-AERLI study (n=240) † Chi-squared test or Wilcoxon test § in years ⱡ AUDIT score ≥3 for women; ≥4 for men *during the previous 4 weeks 1more than 1 HCV at-risk practice during the previous month 2more than 1 problem at the injection site

  11. Results (2) – Evolution of the outcomes • Percentage of participants who reported at least one complication at the injection site • Percentage of participants who reported at least one HCV at-risk practice • p<0.05 : significant difference between M0 and M6 • in the intervention group • p<0.05 : significant difference between M0 and M12 • in the intervention group

  12. Results (3) - Impact of education intervention on HCV risk practices Multivariate model (n = 238, visits = 497)

  13. Results (4) - Impact of education intervention on local complications at the injection site Multivariate model (n=240, visits=520)

  14. Discussion • Limitations • Difficult to have a comparable control group because of clustering • High diversity of PWID population • Lost to follow-up • Self-reports • Positive impact of this innovative education intervention on injecting practices in terms of • A decrease in HCV at-risk practices • A reduction in local complications at the injection site

  15. Conclusion • Innovative aspects of this intervention • Peer-based intervention • Short intervention • Low-cost intervention • Intervention that may be used in several contexts • Needle/syringe programs, safer injecting facilities, outreach intervention in settings where prevalence of PWID is high

  16. Acknowledgements • People who agreed to participate in the study • The ANRS-AERLI study group : M. Beaumont ; G. Boyault ; P.M. Carrrieri ; M. Debrus ; A. Haas ;J.M. Legall; G. Maradan ; M. Mora ; M. Préau ; P. Roux : B. Spire ; M. Suzan-Monti • All participating centers and their staff: M. Debrus (Paris); G. Boyault (Nevers); G. Penavayre (Pau); C. Labbé (Lille); C. Urdiales (Nîmes /Alès); J. Murat (Toulouse); C. Saramago (Grenoble); F. Tempez (Rennes); N. Perrin (Clermont Ferrand); G. Dubosc (Avignon); N. Rodier (Limoges); M. Louanges (La Roche sur Yon); F. Rigaud (Béziers); M. Alvès Da Costa (Nancy)  • Funding

  17. Thank you for your attention

More Related